Tetraphase Pharma Raises $45 Million

Tetraphase Pharmaceuticals Inc., a Watertown, Mass.-based developer of synthetic chemistry technology for drug discovery and development, has raised $45 million in Series C funding. Excel Venture Management led the round, and was joined by return backers CMEA Ventures, Fidelity Biosciences, Flagship Ventures, Mediphase Venture Partners and Skyline Ventures.

North AmericaUSBriefs